Quest Diagnostics Incorporated
Quest Diagnostics Incorporated
Quest Diagnostics Incorporated
DGX
DGX
NYSE
Health Services
Services to the Health Industry
227.86
USD
-0.04
-0.02%
Closed: 07-24 20:00 (UTC+0)
227.86
USD
+0
+0.00%
After Hours: 07-25 00:00 (UTC+0)

DGX Key Statistics

High
233.21
Open
228.00
Volume
1.54M
Low
223.42
Prev. Close
227.90
Trading Value
353.86M
52-Week High
237.78
Relative Volume
1.414
Amplitude (%)
4.30%
52-Week Low
165.78
Turnover Rate
1.39%
Market Cap
25.14B
P/E Ratio (TTM)
24.17
P/E Ratio (Annual)
25.689
P/B Ratio
3.35
P/S Ratio
2.18
Earnings Per Share (EPS)
9.427
Dividend (TTM)
3.737
Dividend Yield
1.44%
Shares Outstanding
110.69M
Currency Unit
USD

DGX Price Performance

7 day
30 day
90 day
180 day
Year to date
1 Year
DGX Money Flow Distribution
DGX Daily Short Sale Volume
DGX Short Interest History
As of 2026-07-26, the Quest Diagnostics Incorporated (DGX) stock price today is 227.86. Based on this price, the company has a market capitalization of $25.14B, with a P/E ratio of 24.17. On 2026-07-26, DGX traded between 223.42 and 233.21. Today’s stock price is 1.99% above the daily low and 2.29% below the daily high, placing DGX near the middle of its most recent trading range. Trading volume currently stands at 1.54M, compared with an average daily volume of 1.09M. This suggests that trading activity is above its usual level than usual. Over the past year, Quest Diagnostics Incorporated shares have traded between 165.78 and 237.78. At today’s price, DGX is 37.45% above its 52-week low and 4.17% below its 52-week high.
Company Name
Quest Diagnostics Incorporated
Sector
Health Services
Industry
Services to the Health Industry
Exchanges
NYSE
Number of Employees
57,000
Lot Size
100
Official Website
Currency Unit
USD
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

DGX FAQ